Pressing ethical issues in considering pediatric deep brain stimulation for obsessive-compulsive disorder.

Area of Science:

• Neuroscience and Psychiatry
• Medical Ethics

Background:

• Deep brain stimulation (DBS) is FDA-approved for refractory obsessive-compulsive disorder (OCD) in adults.
• Pediatric application of DBS for OCD is being considered, with over 100,000 U.S. adolescents affected by refractory OCD.
• Ethical considerations for pediatric DBS in OCD may differ from its use in conditions like dystonia.

Purpose of the Study:

• To explore critical ethical issues surrounding the use of DBS in adolescents diagnosed with OCD.
• To understand clinician perspectives on the complexities of pediatric DBS for refractory OCD.

Main Methods:

• Conducted semi-structured interviews with 25 clinicians treating pediatric patients with refractory OCD.
• Utilized thematic content analysis on coded interview transcripts (MAXQDA 2018) to identify key themes.

Main Results:

• Identified five central themes from clinician responses, with three being particularly relevant to the pediatric DBS setting.
• Clinicians raised concerns about adolescent assent capacity (80%), lack of evidence on pediatric DBS outcomes (68%), and prioritizing other treatments (20%).

Conclusions:

• Addressing clinician concerns requires validated decision support tools for pediatric DBS in OCD.
• Further research is essential to establish clear guidelines for patient selection and understand long-term outcomes of pediatric DBS for OCD.